Connecting you to content on EBSCOhost

Works matching IS 17562872 AND DT 2017 AND VI 9 AND IP 6

Results: 3

1

Efficacy and safety of daily mirabegron 50 mg in male patients with overactive bladder: a critical analysis of five phase III studies.

Published in:

Therapeutic Advances in Urology, 2017, v. 9, n. 6, p. 137, doi. 10.1177/1756287217702797

By:

Tubaro, Andrea;
Batista, José E.;
Nitti, Victor W.;
Herschorn, Sender;
Chapple, Christopher R.;
Blauwet, Mary Beth;
Siddiqui, Emad;
Huang, Moses;
Oelke, Matthias

Publication type:

Article

2

Testosterone suppression with a unique form of leuprorelin acetate as a solid biodegradable implant in patients with advanced prostate cancer: results from four trials and comparison with the traditional leuprorelin acetate microspheres formulation.

Published in:

Therapeutic Advances in Urology, 2017, v. 9, n. 6, p. 127, doi. 10.1177/1756287217701665

By:

Solarić, Mladen;
Bjartell, Anders;
Thyroff-Friesinger, Ursula;
Meani, Davide

Publication type:

Article

3

Renal cell carcinoma with inferior vena cava thrombus extending to the right atrium diagnosed during pregnancy.

Published in:

Therapeutic Advances in Urology, 2017, v. 9, n. 6, p. 155, doi. 10.1177/1756287217701378

By:

Ghanney, Efe C.;
Cavallo, Jaime A.;
Levin, Matthew A.;
Reddy, Ramachandra;
Bander, Jeffrey;
Mella, Maria;
Stone, Joanne;
Schwartz, Myron;
Haines, Kenneth;
Gidwani, Umesh;
Mehrazin, Reza

Publication type:

Article